Related Experiment Video
Updated: Jun 15, 2026
09:16
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts
1The Laboratory of Molecular Pathology, Stem Cell Research Center, Children's Hospital of UPMC, Pittsburgh, PA, USA.
Journal of Cellular and Molecular Medicine
|February 27, 2010
Summary
Transforming growth factor-beta(1) (TGF-β(1)) can dedifferentiate adult muscle cells into stem cell-like progenitors. This novel method generates abundant autologous stem cells for regenerative medicine applications.
Area of Science:
- Cell Biology
- Regenerative Medicine
- Biotechnology
Background:
- Acquiring sufficient stem cell populations for therapeutic use remains a significant challenge.
- Adult somatic cells offer a potential source for autologous stem cells, reducing immune rejection.
- Induced multipotent stem cells present a promising avenue for regenerative medicine.
Purpose of the Study:
- To investigate the potential of transforming growth factor-beta(1) (TGF-β(1)) in inducing stem cell characteristics from myoblasts.
- To explore the mechanism of dedifferentiation triggered by TGF-β(1) in muscle stem cells.
- To evaluate the multipotent differentiation capacity and therapeutic application of TGF-β(1)-induced stem cells.
Main Methods:
- Conditional treatment of C2C12 myoblasts and primary mouse myoblasts with varying concentrations of TGF-β(1).
- Analysis of stem cell marker expression and myogenic protein repression.
- Assessment of cell proliferation and re-entry into the S-phase.
- In vivo studies involving implantation of treated myoblasts into mice for muscle and bone repair.
Main Results:
- Low concentrations of TGF-β(1) induced C2C12 myoblasts to express stem cell markers and repress myogenic proteins, indicating dedifferentiation.
- TGF-β(1) treatment promoted proliferation-arrested myoblasts to re-enter the cell cycle (S-phase).
- Dedifferentiated cells demonstrated multipotent differentiation potential and showed efficacy in repairing dystrophic skeletal muscle and injured bone in vivo.
- Similar dedifferentiation effects were observed in primary mouse myoblasts.
Conclusions:
- TGF-β(1) acts as an effective molecular trigger for the dedifferentiation of skeletal muscle myoblasts.
- This method enables the generation of a large pool of multipotent stem cell-like progenitor cells from easily accessible adult somatic cells.
- The findings support the potential of TGF-β(1)-mediated dedifferentiation for scalable autologous stem cell generation in regenerative medicine.
More Related Videos
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...